Table 2.

Quality of life (QOL) measures within medical and cancer-related categories (N = 692)^a

	N	QOL Physical	QOL Mental	IOC Positive Impact Scale	IOC Negative Impact Scale	BCPT Symptom Scales
Time since diagnosis
<1 year	76	66.1 (21.1)*	70.5 (21.2)*	3.9 (0.6)	2.7 (0.7)	2.1 (0.6)
1-2.9 years	325	69.5 (18.9)*	75.0 (17.6)*	3.8 (0.6)	2.7 (0.7)	2.1 (0.5)
≥3 years	291	72.9 (17.2)*	77.5 (17.2)*	3.8 (0.6)	2.6 (0.7)	2.0 (0.6)
Cancer stage
I	210	73.3 (17.5)	77.2 (17.6)	3.7 (0.6)	2.5 (0.7)	2.0 (0.5)
II	358	70.7 (18.8)	75.4 (18.0)	3.8 (0.6)*	3.0 (0.7)*	2.1 (0.6)
III	124	65.4 (18.8)*	73.3 (18.4)	3.9 (0.5)	2.9 (0.7)*	2.1 (0.5)*
Chemotherapy
No	165	73.5 (17.5)	76.6 (18.3)	3.6 (0.6)	2.5 (0.7)	1.9 (0.5)
Yes	527	69.6 (18.8)	75.3 (17.9)	3.9 (0.5)*	2.7 (0.7)*	2.1 (0.6)*
Endocrine therapy
None	179	69.0 (19.6)	74.2 (19.3)	3.8(0.6)	2.8 (0.8)	2.0 (0.5)
Anti-estrogen only	147	71.5 (20.4)	75.4 (17.5)	3.9 (0.5)	2.7 (0.7)	2.1 (0.6)
Aromatase inhibitor	366	70.9 (17.3)	76.3 (17.5)	3.8 (0.6)	2.6 (0.7)	2.1 (0.6)
Hospitalizations in the last year
None	518	72.5 (18.1)	76.3 (17.8)	3.8 (0.6)	2.6 (0.7)	2.0 (0.5)
Any	174	64.6 (19.0)*	73.3 (18.5)*	3.9 (0.5)	2.8 (0.7)*	2.1 (0.6)
Emergency room visits in the last year
None	586	72.2 (17.5)	76.7 (17.4)	3.8 (0.6)	2.6 (0.7)	2.0 (0.5)
Any	106	61.2 (21.6)*	69.4 (20.0)*	3.9 (0.5)	2.9 (0.8)*	2.2 (0.5)*
Co-morbiditiesb
None	253	75.7 (16.2)*	78.2 (16.0)*	3.9 (0.5)	2.6 (0.7)	2.0 (0.6)*
1	240	70.5 (18.2)*	76.2 (17.3)*	3.7 (0.6)	2.7 (0.7)	2.0 (0.5)*
2	119	67.5 (18.4)*	74.0 (18.6)*	3.8 (0.6)	2.6 (0.7)	2.9 (0.5)*
3 or more	80	59.0 (21.1)*	67.7 (22.2)*	3.8 (0.6)	2.7 (0.8)	2.2 (0.6)*
Number of prescription medicationsc
0-1	279	75.4 (17.4)*	78.6 (16.6)*	3.8 (0.6)	2.6 (0.7)*	2.0 (0.5)*
2-4	329	69.3 (17.5)*	74.6 (17.9)*	3.8 (0.6)	2.7 (0.7)*	2.1 (0.6)*
5 or more	84	59.4 (21.1)*	69.5 (20.8)*	3.7 (0.6)	2.8 (0.8)*	2.2 (0.6)*

^aValues shown are mean (SD).

^bCo-morbidities assessed are current treatment for heart disease, high blood pressure, lung disease, diabetes, ulcer or stomach disease, kidney disease, liver disease, anemia, cancer other than breast, depression, osteoarthritis, back pain, rheumatoid arthritis.

^cPrescription medication counts exclude drugs for breast cancer treatment.

**p < 0.01, continuous variables were modeled in continuous ANOVA, and categorical variables (cancer stage, chemotherapy, and endocrine therapy) were compared using categorical ANOVA where the first category was the referent.